Navigation Links
The long-term fiscal impact of funding cuts for IVF in Denmark
Date:7/6/2011

In 2009, 1,547 ART children were born in public clinics in Denmark, projecting a net tax revenue of 224 million and 247 million in 25 and 50 years respectively. The authors of the study calculated that reductions of 30-50% in ART cycles following the new policy would lead to cost savings of 67 - 111 million for the Danish government in 2034. By 2059 however, when the IVF cohort are 50 years of age, the government would have lost 74 - 123 million due to less tax contributions from fewer children born.

"The most common argument governments use not to fund ART is that fertility treatments are too expensive," said Mark Connolly, lead author of the study, University of Groningen. "Infertility is perceived to be a low priority illness that focuses on unmet needs of present day society. However, when the broader consequences of fertility funding are considered, many of today's fiscal problems such as the ageing population, low birth rates and the declining number of working adults are all partly mitigated by ART conceived children, which in some countries represent 4-5% of the future work force."

An investment of 11,097 for an ART conceived singleton born to a woman younger than 40 is valued at 155,700 and 154,360 in cumulative discounted net tax revenue, when the child is 25 and 50 respectively. For a woman aged over 40, where the cost per birth is 26,147, the investment is valued at 170,470 and 139,600.

"Although investments in reproductive medicine take many years for governments to benefit, the net tax receipts are comparable with naturally conceived children," said Sren Ziebe, co-author of this study, Rigshospital at Copenhagen University. "Both ART conceived and naturally conceived children show a negative balance for the Danish government at age 25. However, at 50 years of age, after 30 years of tax contributions, the net tax benefit of both types of children is considerably high for the state."

The scientists used a modifi
'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
32-047-335-3381
European Society of Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. Birth control has long-term effect on hormone exposure
3. Exposing chicks to maternal stress leads to long-term reproductive success
4. European biodiversity and ecosystem scientists merge and gear up for long-term research
5. Long-term use of diabetes drugs by women significantly increases risk of fractures
6. Vitamin D deficiency in infants and nursing mothers carries long-term disease risks
7. Long-term recovery of reefs from bleaching requires local action to increase resilience
8. Long-term study of orchard ground cover management systems
9. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
10. Study finds multidrug-resistant gram-negative bacteria high in long-term care
11. Neuroscientists discover long-term potentiation in the olfactory bulb
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Biometrics - Global Strategic Business Report" report to their ... Iris Biometrics in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Latin America . Annual ...
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... While hunting among chimpanzees is a group effort, key males, ... They are more likely to initiate a hunt, and hunts ... The findings, which appear in the current issue of ... cooperate to hunt for food, and how individual variation among ...
... computational approach could speed up the process and cut ... the University of Chicago Medical Center and Columbia University ... February 2008 issue of Genome Research, available early online. ... genes and proteins that serve as targets for nearly ...
... the University of Southern California have developed a prostate ... 90 percent of young mice genetically predestined to develop ... Cancer Research, they suggest the same strategy might work ... antigen), a potential diagnostic indicator of prostate cancer. ...
Cached Biology News:Key 'impact hunters' catalyze hunting among male chimpanzees 2Key 'impact hunters' catalyze hunting among male chimpanzees 3Study of successful drug targets could hasten development of new medications 2Study of successful drug targets could hasten development of new medications 3Prostate cancer: Watchful wait or vaccinate? 2Prostate cancer: Watchful wait or vaccinate? 3
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today ... small cell cervical cancer (SCCC) that shows ... the company,s panomic, comprehensive tumor profiling service, identified ... may explain sensitivities and resistance to common ... certain biomarkers may guide treatment strategies in ...
(Date:3/27/2015)... 27. März 2015  Peter Walter wurde ... Science für seine bahnbrechende Arbeit ausgewählt, die ... transportiert werden, sowie für die Entschlüsselung der ... auf Stress nutzen, der mit der Ansammlung ... Professor für Biochemie an der University of ...
(Date:3/27/2015)... SHANGHAI , March 27, 2015 ... a leading open-access R&D capability and technology platform ... device industries, announced today that an Investigational New ... monoclonal antibody for rheumatoid arthritis has been accepted ... Administration (CFDA).  In September 2012, ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - SQI Diagnostics ... announced that after dealing with certain matters, including the ... shareholders held on March 26, 2015 (the "Meeting") was ... April 8, 2015 at 11:00 a.m. ( Toronto ... has been changed from that previous disclosed. The Meeting ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... Former Pfizer executives to lead regulatory affairs group based in Ann ... ... 25 United BioSource Corporation,(UBC) today announced the expansion of its ... Lang, Dr PH. Based,in Ann Arbor, Michigan, the group will provide ...
... CRT-D and upgraded ... System, NATICK, Mass., Feb. 25 Boston Scientific,Corporation (NYSE: ... three products in its Cardiac Rhythm Management,business. They are:, ... helps protect patients at risk of sudden cardiac ...
... 25 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... first Phase 3 clinical trial with AZ-004 ... being developed for the treatment of,acute agitation ... Alexza,believes the novel, non-invasive nature and rapid ...
Cached Biology Technology:United BioSource Expands Regulatory Affairs Capabilities 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 3Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5
Vesicle Associated Membrane Protein (VAMP 1/2)...
...
Anti-OSMR Monoclonal Antibody Research Focus: cytokine/growth factor Storage: 4C Shipping Temperature: 4C...
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis....
Biology Products: